Citius Oncology, Inc. financial data

Symbol
CTOR on Nasdaq
Location
11 Commerce Drive, 1 St Floor, Cranford, NJ
State of incorporation
Cayman Islands
Fiscal year end
December 31
Former names
TenX Keane Acquisition (to 8/5/2024)
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.06 %
Return On Equity -90.3 %
Return On Assets 3.21 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.36M shares
Common Stock, Shares, Outstanding 2.34M shares -3.1%
Entity Public Float 69.5M USD
Common Stock, Value, Issued 167 USD -31%
Weighted Average Number of Shares Outstanding, Basic 4.31M shares -34.7%
Weighted Average Number of Shares Outstanding, Diluted 4.31M shares -34.7%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 1.32M USD +92.4%
Operating Income (Loss) -1.32M USD -92.4%
Nonoperating Income (Expense) 3.25M USD -22%
Net Income (Loss) Attributable to Parent 1.93M USD -59%
Earnings Per Share, Basic 0.24 USD/shares -7.69%
Earnings Per Share, Diluted 0.24 USD/shares -42.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 41K USD -91.1%
Assets 49.2M USD -29.6%
Accrued Liabilities, Current 486K USD +346%
Liabilities, Current 3.08M USD +564%
Retained Earnings (Accumulated Deficit) -3.04M USD -137462%
Stockholders' Equity Attributable to Parent -3.04M USD -154369%
Liabilities and Equity 49.2M USD -29.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -192K USD -13.6%
Net Cash Provided by (Used in) Financing Activities -24.5M USD
Net Cash Provided by (Used in) Investing Activities 24.7M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 2.34M shares -3.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 584 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%